<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.2'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//www.bioredbrasil.com.br/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://www.bioredbrasil.com.br/tenho-lupus-e-agora-entenda-os-primeiros-passos-depois-do-diagnostico/</loc>
  <lastmod>2026-10-09T20:58:49Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Tenho lúpus e agora? Entenda os primeiros passos depois do diagnóstico</news:title>
   <news:publication_date>2026-10-09T21:30:08Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/biosummit-2026-promove-tres-aulas-sobre-acesso-a-tratamentos-no-sus-e-participacao-social/</loc>
  <lastmod>2026-10-09T21:02:51Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>BioSummit 2026 promove três aulas sobre acesso a tratamentos no SUS e participação social</news:title>
   <news:publication_date>2026-10-09T20:22:27Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/anvisa-aprova-combinacao-com-insulina-de-aplicacao-semanal-para-diabetes-tipo-2/</loc>
  <lastmod>2026-10-05T19:53:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Anvisa aprova combinação com insulina de aplicação semanal para diabetes tipo 2.</news:title>
   <news:publication_date>2026-10-09T13:30:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/semaglutida-2-mg-e-associada-a-menor-risco-cardiovascular-que-troca-para-tirzepatida-em-analise-de-vida-real/</loc>
  <lastmod>2026-10-05T20:30:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Semaglutida 2 mg é associada a menor risco cardiovascular que troca para tirzepatida em análise de vida real</news:title>
   <news:publication_date>2026-10-08T17:30:57Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/ultimos-dias-representantes-de-organizacoes-da-sociedade-civil-oscs-podem-se-inscrever-ate-amanha-para-participar-das-reunioes-da-conitec/</loc>
  <lastmod>2026-10-08T13:54:17Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Últimos dias: representantes de Organizações da Sociedade Civil (OSCs) podem se inscrever até amanhã para participar das reuniões da Conitec</news:title>
   <news:publication_date>2026-10-08T13:38:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.bioredbrasil.com.br/campanha-destaca-informacao-de-qualidade-na-conscientizacao-sobre-tdah/</loc>
  <lastmod>2026-10-05T12:01:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Biored Brasil</news:name>
    <news:language>pt</news:language>
   </news:publication>
   <news:title>Campanha destaca informação de qualidade na conscientização sobre TDAH</news:title>
   <news:publication_date>2026-10-08T13:30:23Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
